{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:42:24Z","timestamp":1771652544564,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer Inc","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4039-7","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:03:39Z","timestamp":1559034219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data"],"prefix":"10.1186","volume":"19","author":[{"given":"Jie","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalal A.","family":"Aram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-jun","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian\u2019an","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan S.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"4039_CR1","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMra0808853","volume":"360","author":"BH Segal","year":"2009","unstructured":"Segal BH. Aspergillosis. N Engl J Med. 2009;360:1870\u201384.","journal-title":"N Engl J Med"},{"issue":"8","key":"4039_CR2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"Dimitrios\u00a0P. Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis. 2010;50:1091\u2013100.","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"4039_CR3","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1086\/651262","volume":"50","author":"Peter\u00a0G. Pappas","year":"2010","unstructured":"Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50:1101\u201311.","journal-title":"Clinical Infectious Diseases"},{"key":"4039_CR4","doi-asserted-by":"crossref","unstructured":"de Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra TF, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) consensus group. Clin Infect Dis. 2008;46:1813\u201321.","DOI":"10.1086\/588660"},{"key":"4039_CR5","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1086\/597395","volume":"48","author":"C Cordonnier","year":"2009","unstructured":"Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis. 2009;48:1042\u201351.","journal-title":"Clin Infect Dis"},{"key":"4039_CR6","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1086\/496927","volume":"41","author":"J Maertens","year":"2005","unstructured":"Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis. 2005;41:1242\u201350.","journal-title":"Clin Infect Dis"},{"key":"4039_CR7","first-page":"88","volume":"85","author":"S De Marie","year":"2000","unstructured":"De Marie S. New developments in the diagnosis and management of invasive fungal infections. Haematologica. 2000;85:88\u201393.","journal-title":"Haematologica."},{"key":"4039_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/00004728-198705000-00033","volume":"11","author":"RH Hruban","year":"1987","unstructured":"Hruban RH, Meziane MA, Zerhouni EA, Wheeler PS, Dumler JS, Hutchins GM. Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. J Comput Assist Tomogr. 1987;11:534\u20136.","journal-title":"J Comput Assist Tomogr"},{"key":"4039_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1148\/radiology.157.3.3864189","volume":"157","author":"JE Kuhlman","year":"1985","unstructured":"Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985;157:611\u20134.","journal-title":"Radiology."},{"key":"4039_CR10","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/1097-0142(197805)41:5<2028::AID-CNCR2820410551>3.0.CO;2-#","volume":"41","author":"DP Orr","year":"1978","unstructured":"Orr DP, Myerowitz RL, Dubois PJ. Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer. 1978;41:2028\u201339.","journal-title":"Cancer."},{"key":"4039_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1997.15.1.139","volume":"15","author":"D Caillot","year":"1997","unstructured":"Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 1997;15:139\u201347.","journal-title":"J Clin Oncol"},{"key":"4039_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1086\/509917","volume":"44","author":"RE Greene","year":"2007","unstructured":"Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44:373\u20139.","journal-title":"Clin Infect Dis"},{"key":"4039_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/bmt.2008.427","volume":"44","author":"FL Dignan","year":"2009","unstructured":"Dignan FL, Evans SO, Ethell ME, Shaw BE, Davies FE, Dearden CE, et al. An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. Bone Marrow Transplant. 2009;44:51\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"4039_CR14","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1182\/blood-2016-10-743880","volume":"128","author":"Y Ji","year":"2016","unstructured":"Ji Y, Sun Y, Yan C, Huang X, Liu D, Liu Q. The efficacy of CT-diagnostic-driven antifungal strategy with voriconazole for invasive aspergillosis in patients with hematological diseases: a multicenter, prospective study. Blood. 2016;128:2370.","journal-title":"Blood."},{"key":"4039_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/M13-2508","volume":"162","author":"KA Marr","year":"2015","unstructured":"Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015;162:81\u20139.","journal-title":"Ann Intern Med"},{"key":"4039_CR16","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1128\/AAC.02809-13","volume":"58","author":"P Liu","year":"2014","unstructured":"Liu P, Mould DR. Population pharmacokinetic-pharmacodynamic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis. Antimicrob Agents Chemother. 2014;58:4727\u201336.","journal-title":"Antimicrob Agents Chemother"},{"key":"4039_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijantimicag.2009.01.008","volume":"34","author":"K Matsumoto","year":"2009","unstructured":"Matsumoto K, Ikawa K, Abematsu K, Fukunaga N, Nishida K, Fukamizu T, et al. Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes. Int J Antimicrob Agents. 2009;34:91\u20134.","journal-title":"Int J Antimicrob Agents"},{"key":"4039_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00228-008-0574-7","volume":"65","author":"G Wang","year":"2009","unstructured":"Wang G, Lei HP, Li Z, Tan ZR, Guo D, Fan L, et al. The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers. Eur J Clin Pharmacol. 2009;65:281\u20135.","journal-title":"Eur J Clin Pharmacol"},{"key":"4039_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00007691-199806000-00001","volume":"20","author":"M Kimura","year":"1998","unstructured":"Kimura M, Ieiri I, Mamiya K, Urae A, Higuchi S. Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population. Ther Drug Monit. 1998;20:243\u20137.","journal-title":"Ther Drug Monit"},{"key":"4039_CR20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR III, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1\u2013e60.","journal-title":"Clin Infect Dis"},{"key":"4039_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.2016.152900","volume":"102","author":"F Tissot","year":"2017","unstructured":"Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017;102:433\u201344.","journal-title":"Haematologica."},{"key":"4039_CR22","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1093\/cid\/civ154","volume":"60","author":"M Stanzani","year":"2015","unstructured":"Stanzani M, Sassi C, Lewis RE, Tolomelli G, Bazzocchi A, Cavo M, et al. High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies. Clin Infect Dis. 2015;60:1603\u201310.","journal-title":"Clin Infect Dis"},{"key":"4039_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","volume":"19","author":"D Caillot","year":"2001","unstructured":"Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol. 2001;19:253\u20139.","journal-title":"J Clin Oncol"},{"key":"4039_CR24","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/cid\/cir122","volume":"52","author":"SP Georgiadou","year":"2011","unstructured":"Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011;52:1144\u201355.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4039-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4039-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4039-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:06:30Z","timestamp":1590534390000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4039-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4039"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4039-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"22 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the International Conference on Harmonization Good Clinical Practice Guidelines and ethical principles originating in or derived from the Declaration of Helsinki, approved by the appropriate Institutional Review Boards and Independent Ethics Committees of the investigational centers (Additional\u00a0file\u00a0) and registered on ClinicalTrials.gov (NCT00531479). All patients provided written, informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JJ, DW, Y-JL, HM, XC, and ISS have nothing to disclose. TFP has received research support from or served on advisory boards\/consultant for Astellas, Basilea, Gilead, Merck, Pfizer, Scynexis, and Toyama. YL, SP, JLY, JAA, and XZ are employees of Pfizer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"471"}}